Molecular Epidemiology of Pancreatic Cancer

Cancer Journal

Volumn 7, Issue 4, 2001, Pages 259-265

  Li, Donghui ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Carcinogen metabolism; DNA adduct; Etiology; Genetic susceptibility; K ras mutation; Oxidative DNA damage; Polymorphism

Indexed keywords

CARCINOGEN; TUMOR MARKER;

DNA ADDUCT; EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETICS; HUMAN; LIPID PEROXIDATION; METABOLISM; MUTATION; ONCOGENE RAS; OXIDATIVE STRESS; PANCREAS TUMOR; REVIEW;

CARCINOGENS; DNA ADDUCTS; EPIDEMIOLOGY, MOLECULAR; GENES, RAS; HUMANS; LIPID PEROXIDATION; MUTATION; OXIDATIVE STRESS; PANCREATIC NEOPLASMS; POLYMORPHISM, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0035409102     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. American Cancer Society. Cancer Figures and Facts, 2000. Atlanta: American Cancer Society, 2000.
2. Anderson KE, Potter JD, Mack TM. Pancreatic Cancer In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention New York. Oxford University Press, 1996 725-771.
3. Gold EB, Goldin SB. Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin North Am 1998;7:67-91.
4. Ahlgren JD Epidemiology and risk factors in pancreatic cancer Semin Oncol 1996;23:241-250
5. Mack TM, Yu MC, Hanisch R et al. Pancreas cancer and smoking, beverage consumption, and past medical history J Natl Cancer Inst 1986;76 49-60.
6. Silverman DT, Dunn JA, Hoover RN et al Cigarette smoking and pancreas cancer: a case-control study based on direct interview. J Natl Cancer Inst 1994;86 1510-1516.
7. Muscat JE, Stellman SD, Hoffman D et al. Smoking and pancreatic cancer in men and women. Cancer Epidemiol Biomarkers Prev 1997;6:15-19
8. Ji BT, Chow WH, Gridley G et al Dietary factors and the risk of pancreatic cancer: a case-control study in Shanghai, China Cancer Epidemiol Biomarkers Prev 1995;4:885-893
9. Ghadirian P, Baillargeon J, Simard A et al. Food habits and pancreatic cancer: a case-control study of the Francophone Community in Montreal, Canada Cancer Epidemiol Biomarkers Prev 1995;4 895-899.
10. Knekt P, Steineck G, Jarvinen R et al Intake of fried meat and risk of cancer a follow-up study in Finland. Int J Cancer 1994, 59:756-760
11. Ohba S, Nishi M, Miyake H Eating habits and pancreatic cancer. Int J Pancreatol 1996;20:37-42
12. Norell S, Ahlbom A, Olin R et al Occupational factors and pancreatic cancer Br J Ind Med 1986;43 775-778
13. Kauppmen T, Partanen T, Degerth R et al. Pancreatic cancer and occupational exposures Epidemiology 1995;6:498-502
14. Park RM, Mirer FE A survey of mortality at two automotive engine manufacturing plants Am J Ind Med 1996;30:664-673
15. Bardin JA, Eisen EA, Tolbert PE et al. Mortality studies of machining fluid exposure in the automobile industry V: a case-control study of pancreatic cancer Am J Ind Med 1997;32:240-247.
16. Garabrani DH, Held J, Langholz B et al. DDT and related compounds and risk of pancreatic cancer. J Natl Cancer Inst 1992, 84:764-771
17. Fryzek J, Garabrant DH, Harlow SD et al. A case-control study of self-reported exposures to pesticides and pancreas cancer in Southern Michigan Int J Cancer 1997;72 62-67.
18. Bartsch H, Rojas M, Nair U et al. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers. Cancer Detect Prev 1999;23:445-453
19. Shields PG, Harris CC Molecular epidemiology and the genetics of environmental cancer. JAMA 1991;266:681-687.
20. Perera PP. Molecular epidemiology, insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996; 88:496-509
21. Wei Q, Spitz MR The role of DNA repair capacity in susceptibility to lung cancer: a review. Cancer Metast Rev 1997;16 295-307
22. Spitz MR, Wu X, Jiang H et al Mutagen sensitivity as a marker of cancer susceptibility J Cell Biochem 1996;S25:80-84.
23. Nair U, Bartsch H Metabolic polymorphisms as susceptibility markers for lung and oral cavity cancer. IARC Scientific Publications (Lyon) 2001,154:271-290
24. Greenblatt MS, Bennett WP, Hollstein M et al Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878.
25. Hussain SP, Harris CC. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 1998;58:4023-4037.
26. Cuzick J, Routledge MN, Jenkins D et al. DNA adducts in different tissues of smokers and non-smokers Int J Cancer 1990;45: 673-678.
27. Anderson KE, Hammons GJ, Kadlubar FK et al. Metabolic activation of aromatic amines by human pancreas Carcinogenesis 1997; 18:1085-1092.
28. Wang MY, Abbruzzese JL, Friess H et al. DNA adducts in human pancreatic tissues and their potential role in carcinogenesis Cancer Res 1998;58:38-41
29. Li D, Firozi PF, Zhang W et al. DNA adducts, genetic polymorphisms and K-ras mutation in human pancreatic cancer Proc Am Assoc Cancer Res 2001;42:A3567.
30. Weiderpass E, Partanen T, Kaaks R et al Occurrence, trends, and environmental etiology of pancreatic cancer Scan J Work Environ Health 1998;24:165-174
31. Garabrant DH, Held J, Langholz B et al DDT and related compounds and risk of pancreatic cancer J Natl Cancer Inst 1992; 84:764-771.
32. Hoppin JA, Tolbert PE, Holly EA et al Pancreatic cancer and serum organochlorine levels Cancer Epidemiol Biomarkers Prev 2000;9:199-205
33. Schwartz GG, Reis IM Is cadmium a cause of human pancreatic cancer? Cancer Epidemiol Biomarkers Prev 2000;9:139-145
34. Ames BN, Shigenaga MK, Hagen TM Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993, 90:7915-7922.
35. Guyton KZ, Kensler TW. Oxidative mechanisms in carcinogenesis. Br Med Bull 1993;49:523-544.
36. Schoenberg MH, Buchler M, Gaspar M et al The involvement of oxygen radicals in acute pancreatitis. Gut 1990;31:1138-1143
37. Schoenberg MH, Buchler M, Pietrzyk C et al. Lipid peroxidation and glutathione metabolism in chrome pancreatitis. Pancreas 1995;10:36-43
38. Wereszcynska-Siemiatkowska U, Dabrowski A, Jedynak M et al. Oxidative stress as an early prognostic factor in acute pancreatitis (AP) us correlation with serum phospholipase A2 (PLA2) and plasma polymorphonuclear elastase (PMN-E) in different-severity forms of human AP Pancreas 1998;17:163-168
39. Nair J, Link KH, Beger HG et al Detection of elevated lipid peroxidation-induced etheno-DNA adducts in human chronic pancreatitis Proc Am Assoc Cancer Res 1999,40 A4256.
40. Thompson PA, Seyedi F, Lang NP et al Comparison of DNA adduct levels associated with exogenous and endogenous exposures in human pancreas in relation to metabolic genotype. Mutat Res 1999;424:263-274
41. Kadlubar FF, Anderson KE, Hāussermann S et al Comparison of DNA adduct levels associated with oxidative stress in human pancreas Mutat Res 1998;405:125-133.
42. Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 1999;424:83-95.
43. Lau SS, Peters MMCG, Kleiner HE et al Linking the metabolism of hydroquinone to its nephrotoxicity and nephrocarcinogenicity. Adv Exp Med Biol 1996;387:267-273
44. Li D, Friess H, Abbruzzese JL. 8-Hydroxyguanine and other DNA damage in human pancreatic cancer Proc Am Assoc Cancer Res 1999;40:A4425.
45. Lee HC, Yoon YB, Kim CY Association between genetic polymorphisms of the cytochromes P-450 (1A1, 2D6, and 2E1) and the susceptibility to pancreatic cancer Korean J Intern Med 1997;12: 128-136.
46. Bartsch H, Malaveille C, Lowenfels AB et al. Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk The International Pancreatic Disease Study Group Eur J Cancer Prev 1998;7:215-223
47. Liu G, Ghadirian P, Vesprini D et al Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma. Br J Cancer 2000;82:1646-1649
48. Landi MT, Bertazzi PA, Shields PG et al. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 1994;4:242-246.
49. Kato S, Bowman ED, Harrington AM et al. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo J Nad Cancer Inst 1995;87 902-907.
50. Shields PG, Bowman ED, Harrington AM et al. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes Cancer Res 1993;53:3486-3492.
51. Butkiewicz D, Grzybowska E, Hemminki H et al Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms Mutat Res 1998;415:97-108.
52. Ichiba M, Hagmar L, Rannug A et al Aromatic DNA adducts, micronuclei and genetic polymorphisms for CYP1A1 and GSTM1 in chimney sweeps Carcinogenesis 1994;15:1347-1352.
53. o-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 1990;50:6119-6129
54. Pegg AE Methylation of the Opposition of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents. Cancer Invest 1984;2:223-231
55. o-alkylguanine-DNA alkyltransferase: identification of a missense variation in the active site region. Pharmacogenetics 1999;9: 91-87.
56. o-alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:339-342
57. Jiao L, Firozi PF, Connor T et al Codon 143 polymorphism of AGT gene in pancreatic cancer Proc Am Assoc Cancer Res 2001; 42:A1844.
58. Berrozpe G, Schaeffer J, Peinado MA et al Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer 1994;58:185-191
59. Blanck HM, Tolbert PE, Hoppin JA. Patterns of genetic alterations in pancreatic cancer: a pooled analysis Environ Mol Mutagen 1999;33:111-122.
60. Malats N, Porta M, Corominas JM et al Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption Int J Cancer 1997;70:661-667
61. Berger DH, Chang H, Wood M et al Mutational activation of K-ras in non-neoplastic exocrine pancreatic lesions in relation to cigarette smoking status Cancer 1999;85:326-329
62. Hruban RH, van Mansfield ADM, Offerhaus GJA et al. K-ras oncogene activation in adenocarcinoma of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-554
63. Sugio K, Gazdar AF, Albores-Saavedra J et al High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters Carcinogenesis 1996;17:303-309.
64. Cooper GM Role of oncogenes and tumor suppressor genes in the pathogenesis of neoplasms In Cooper GM, ed Oncogenes Sudbury, MA. Jones & Bartlett Publishers, 1990 141-162
65. Porta M, Malats N, Jariod M et al. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group Lancet 1999;354:2125-2129.
66. Porta M, Vioque J, Malats N et al. Diet and K-ras mutation in pancreatic cancer. Proc Am Assoc Cancer Res 2001;42 A826.